Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 173-178 , December 2009

The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women

  • Tanvi Agrawal

      Affiliations

    • Institute of Pathology - ICMR, Safdarjung Hospital Campus, New Delhi 110029, India
    • ,
  • Vikas Vats

      Affiliations

    • Institute of Pathology - ICMR, Safdarjung Hospital Campus, New Delhi 110029, India
    • ,
  • Sudha Salhan

      Affiliations

    • Department of Gynecology, Safdarjung Hospital, New Delhi 110029, India
    • ,
  • Aruna Mittal

      Affiliations

    • Institute of Pathology - ICMR, Safdarjung Hospital Campus, New Delhi 110029, India
    • Corresponding Author InformationCorresponding author at: Institute of Pathology - ICMR, Safdarjung Hospital Campus, New Delhi 110029, India. Tel.: +91 11 26198 402x05; fax: +91 11 26198 401.

Received 15 December 2008 ,Revised 17 July 2009 ,Accepted 26 July 2009.

References 

  1. Agrawal T, Vats V, Salhan S, Mittal A. Mucosal and peripheral immune responses to chlamydial heat shock proteins in women infected with Chlamydia trachomatis. Clin. Exp. Immunol. 2007;148:461–467
  2. Agrawal T, Vats V, Wallace PK, Salhan S, Mittal A. Cervical cytokine responses in women with primary or recurrent chlamydial infection. J. Interf. Cytokine Res. 2007;27:221–226
  3. Agrawal T, Vats V, Salhan S, Mittal A. Primary and secondary immune response of mucosal and peripheral lymphocytes during Chlamydia trachomatis infection. FEMS Immunol. Med. Microbiol. 2007;49:280–287
  4. Agrawal T, Vats V, Wallace P, Salhan S, Mittal A. Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection. Reprod. Biol. Endocrinol. 2008;6:46
  5. Agrawal T, Vats V, Wallace P, Singh A, Salhan S, Mittal A. Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during C. trachomatis infection. Clin. Micobiol. Inf. 2009;15:50–59
  6. Agrawal T, Gupta R, Dutta R, Srivastava P, Bhengraj AR, Salhan S, et al. Protective or pathogenic immune response to genital chlamydial infection in women—a possible role of cytokine secretion profile of cervical mucosal cells. Clin. Immunol. 2009;130:347–354
  7. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon-gamma mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 1993;90:3998–4002
  8. Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 2003;111:1757–1769
  9. Darville T, O’Neill JM, Andrews CW, Nagarajan UM, Stahl L, Ojcius DM. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J. Immunol. 2003;171:6187–6197
  10. Dong-Ji Z, Yang X, Shen C, Lu H, Murdin A, Brunham RC. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect. Immun. 2000;68:3074–3078
  11. Ekong FE, Okenu DN, Mania-Pramanik J, He Q, Igietseme JU, Ananaba GA, et al. A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin. FEMS Immunol. Med. Microbiol. 2009;55:280–291
  12. Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev. Infect. Dis. 1985;7:717–725
  13. He Q, Martinez-Sobrido L, Eko FO, Palese P, Garcia-Sastre A, Lyn D, et al. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology. 2007;23:1–10
  14. Igietseme JU, Black CM, Caldwell HD. Chlamydia vaccines: strategies and status. Bio Drugs. 2002;16:19–35
  15. Johnson RM. Murine oviduct epithelial cell cytokine responses to Chlamydia muridarum infection include interleukin-12-p70 secretion. Infect. Immun. 2004;72:3951–3960
  16. Kelly KA. T-lymphocyte trafficking to the female reproductive tract mucosae. In:  Bavoil PM,  Wyrick PB editor. Chlamydia: Genomics and Pathogenesis. Norfolk, UK: Horizon Bioscience; 2006;p. 413–435
  17. Loomis WP, Starnbach MN. T cell responses to Chlamydia trachomatis. Curr. Opin. Microbiol. 2002;5:87–91
  18. Mittal A, Kapur S, Gupta S. Chlamydial cervicitis: Role of culture, enzyme immunoassay and Giemsa cytology in diagnosis. APMIS. 1993;101:37–40
  19. Mittal A, Kapur S, Gupta S. Host immune response in chlamydial cervicitis. Br. J. Biomed. Sci. 1996;53:214–220
  20. Mittal A, Rastogi S, Reddy BS, Verma S, Salhan S, Gupta E. Enhanced immunocompetent cells in chlamydial cervicitis. J. Rep. Med. 2004;49:671–677
  21. Morrison RP, Caldwell HD. Immunity to murine chlamydial genital infection. Infect. Immun. 2002;70:2741–2751
  22. Pal S, Hui W, Peterson EM, de la Maza LM. Factors influencing the induction of infertility in mouse model of Chlamydia trachomatis ascending genital tract infection. J. Med. Microbiol. 1998;47:599–605
  23. Parks KS, Dixon PB, Richey CM, Hook EW. Spontaneous clearance of Chlamydia trachomatis infection in untreated patients. Sex. Transm. Dis. 1997;24:229–235
  24. Portig I, Goodall JC, Bailey RL, Gaston JS. Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection. Clin. Diagn. Lab. Immunol. 2003;10:103–107
  25. Prebeck S, Kirschning C, Durr S, da Costa C, Brand K, Redecke V, et al. Predominant role of Toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J. Immunol. 2001;167:3316–3323
  26. Punnonen R, Terho P, Nikkanen V, Meurman O. Chlamydial serology in infertile women by immunofluorescence. Fertil. Steril. 1979;31:656–659
  27. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect. Immun. 1991;59:925–931
  28. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, et al. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 1997;99:77–87
  29. Rastogi S, Kapur S, Salhan S, Mittal A. Chlamydia trachomatis infection in pregnancy: risk factor for an adverse outcome. Br. J. Biomed. Sci. 1999;56:94–98
  30. Rastogi S, Salhan S, Mittal A. Detection of Chlamydia trachomatis antigen in spontaneous abortions. Is this organism a primary or secondary indicator of risk?. Br. J. Biomed. Sci. 2000;57:126–129
  31. Reddy BS, Rastogi S, Verma S, Das B, Salhan S, Mittal A. Cytokine expression pattern in the genital tract of C. trachomatis positive infertile women-implication for T cell responses. Clin. Exp. Immunol. 2004;137:552–558
  32. Rottenberg ME, Gigliotti-Rothfuchs A, Wigzell H. The role of IFN-gamma in the outcome of chlamydial infection. Curr. Opin. Immunol. 2002;14:444–451
  33. Singh V, Rastogi S, Garg S, kapur S, Kamar A, Salhan S, et al. Polymerase chain reaction for detection of endocervical Chlamydia trachomatis inf3ection in women attending a gynecology out patient department in India. Acta Cyt. 2002;46:540–544
  34. Singh V, Salhan S, Das BC, Mittal A. Predominance of Chlamydia rachomatis serovars associated with urogenital infections in females in New Delhi, India. J. Clin. Microbiol. 2003;41:2700–2702
  35. Srivastava P, Jha R, Salhan S, Mittal A. In Infertile women, cells from Chlamydia trachomatis infected site release higher levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha upon heat shock protein stimulation than fertile women. Rep. Biol. Endocrinol. 2008;6:20
  36. Stamm WE. Chlamydia trachomatis infections: progress and problems. J. Infect. Dis. 1999;179:S380–S383
  37. Starnbach MN, Loomis WP, Ovendale P, Regan D, Hess B, Alderson MR, et al. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+ T cell response. J. Immunol. 2003;171:4742–4749
  38. Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae. J. Exp. Med. 1998;188:809–818
  39. Sweet RL, Blankfort-Doyle M, Robbie MO, Schachter J. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA. 1986;255:2246–2250
  40. Wang C, Tang J, Crowley-Nowick PA, Wilson CM, Kaslow RA, Geisler WM. Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents. Clin. Exp. Immunol. 2005;142:548–554
  41. WHO . Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva, Switzerland: World Health Organization; 2001;

PII: S0165-0378(09)00458-6

doi: 10.1016/j.jri.2009.07.013

Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 173-178 , December 2009

Article Tools

* Image Usage & Resolution